These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 8757566)

  • 21. Clinical and Host Biological Factors Predict Colectomy Risk in Children Newly Diagnosed With Ulcerative Colitis.
    Hyams JS; Brimacombe M; Haberman Y; Walters T; Gibson G; Mo A; Mack D; Griffiths A; Boyle B; LeLeiko N; Markowitz J; Rosh J; Patel A; Shah S; Baldassano R; Pfefferkorn M; Sauer C; Dailey J; Venkateswaran S; Kugathasan S; Denson LA
    Inflamm Bowel Dis; 2022 Feb; 28(2):151-160. PubMed ID: 33904583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Infliximab efficacy in pediatric ulcerative colitis.
    Eidelwein AP; Cuffari C; Abadom V; Oliva-Hemker M
    Inflamm Bowel Dis; 2005 Mar; 11(3):213-8. PubMed ID: 15735427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Bilateral pneumothorax and hemorrhagic rectocolitis].
    Heloury Y; Plattner V; David V; Nomballais MF
    Arch Pediatr; 1996 Sep; 3(9):874-6. PubMed ID: 8949348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of extended ulcerative colitis (severe colitis excluded)].
    Beaugerie L; Blain A; Brazier F; Gornet JM; Parc Y
    Gastroenterol Clin Biol; 2004 Oct; 28(10 Pt 2):974-83. PubMed ID: 15672569
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of ulcerative colitis.
    Ludwig D; Stange EF
    Hepatogastroenterology; 2000; 47(31):83-9. PubMed ID: 10690588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adverse effects of sulfasalazine and treatment of ulcerative colitis with mesalazine.
    Nakajima H; Munakata A; Yoshida Y
    J Gastroenterol; 1995 Nov; 30 Suppl 8():115-7. PubMed ID: 8563870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Presenting features and disease course of pediatric ulcerative colitis.
    Aloi M; D'Arcangelo G; Pofi F; Vassallo F; Rizzo V; Nuti F; Di Nardo G; Pierdomenico M; Viola F; Cucchiara S
    J Crohns Colitis; 2013 Dec; 7(11):e509-15. PubMed ID: 23583691
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Infliximab three-dose induction regimen in severe corticosteroid-refractory ulcerative colitis: early and late outcome and predictors of colectomy.
    Monterubbianesi R; Aratari A; Armuzzi A; Daperno M; Biancone L; Cappello M; Annese V; Riegler G; Orlando A; Viscido A; Meucci G; Gasbarrini A; Guidi L; Lavagna A; Sostegni R; Onali S; Papi C; Kohn A;
    J Crohns Colitis; 2014 Aug; 8(8):852-8. PubMed ID: 24472490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does infliximab prevent colectomy in acute and chronic active ulcerative colitis?
    Dan-Nielsen S; Wewer V; Paerregaard A; Hansen LF; Nielsen RG; Lange A; Jakobsen C
    J Pediatr Gastroenterol Nutr; 2014 Jun; 58(6):768-72. PubMed ID: 24572593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Colorectal cancer risk and mortality in patients with ulcerative colitis.
    Langholz E; Munkholm P; Davidsen M; Binder V
    Gastroenterology; 1992 Nov; 103(5):1444-51. PubMed ID: 1358741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An oral preparation of mesalamine as long-term maintenance therapy for ulcerative colitis. A randomized, placebo-controlled trial. The Mesalamine Study Group.
    Ann Intern Med; 1996 Jan; 124(2):204-11. PubMed ID: 8533995
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Severe eosinophilic infiltration in colonic biopsies predicts patients with ulcerative colitis not responding to medical therapy.
    Zezos P; Patsiaoura K; Nakos A; Mpoumponaris A; Vassiliadis T; Giouleme O; Pitiakoudis M; Kouklakis G; Evgenidis N
    Colorectal Dis; 2014 Dec; 16(12):O420-30. PubMed ID: 25040651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term clinical outcomes and factors predictive of relapse after 5-aminosalicylate or sulfasalazine therapy in patients with mild-to-moderate ulcerative colitis.
    Lee HJ; Jung ES; Lee JH; Hong SP; Kim TI; Kim WH; Cheon JH
    Hepatogastroenterology; 2012; 59(117):1415-20. PubMed ID: 22683958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medical therapy for ulcerative colitis in childhood.
    Ament ME; Vargas JH
    Semin Pediatr Surg; 1994 Feb; 3(1):28-32. PubMed ID: 7914811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of ulcerative colitis with oral 5-aminosalicylic acid including patients with adverse reactions to sulfasalazine.
    Habal FM; Greenberg GR
    Am J Gastroenterol; 1988 Jan; 83(1):15-9. PubMed ID: 2892391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis.
    Ardizzone S; Maconi G; Russo A; Imbesi V; Colombo E; Bianchi Porro G
    Gut; 2006 Jan; 55(1):47-53. PubMed ID: 15972298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inflammatory disease of the colon: ulcerative colitis and Crohn's colitis.
    Ament ME
    J Pediatr; 1975 Mar; 86(3):322-34. PubMed ID: 234530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The treatment of ulcerative colitis].
    Turunen U; Järvinen HJ
    Duodecim; 1993; 109(2):145-51. PubMed ID: 7912179
    [No Abstract]   [Full Text] [Related]  

  • 39. [Current medical treatment of hemorrhagic rectocolitis].
    Gendre JP
    Gastroenterol Clin Biol; 1994; 18(2 Pt 3):T9-12. PubMed ID: 7913901
    [No Abstract]   [Full Text] [Related]  

  • 40. Infliximab in ulcerative colitis: the impact of preoperative treatment on rates of colectomy and prescribing practices in the province of British Columbia, Canada.
    Moore SE; McGrail KM; Peterson S; Raval MJ; Karimuddin AA; Phang PT; Bressler B; Brown CJ
    Dis Colon Rectum; 2014 Jan; 57(1):83-90. PubMed ID: 24316950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.